These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15678390)
1. [Immunophenotyping in modern leukemia diagnosis]. Kern W; Diem H; Haferlach T Dtsch Med Wochenschr; 2005 Feb; 130(5):215-9. PubMed ID: 15678390 [No Abstract] [Full Text] [Related]
2. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping. Lanza F Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695 [No Abstract] [Full Text] [Related]
3. Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines? Basso G; Lanza F; Orfao A; Benè M; Borowitz M; Campana D; Lacombe F; Ludwig WD; Porwitt-MacDonald A; Rothe G; Dworzac M; J Biol Regul Homeost Agents; 2002; 16(4):257-8. PubMed ID: 12597641 [No Abstract] [Full Text] [Related]
4. Clinical Cytometry on both sides of the Atlantic, 2011. Preffer FI; Gratama JW Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905 [No Abstract] [Full Text] [Related]
5. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics. Nicholson JK Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714 [TBL] [Abstract][Full Text] [Related]
6. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Davis BH; Foucar K; Szczarkowski W; Ball E; Witzig T; Foon KA; Wells D; Kotylo P; Johnson R; Hanson C; Bessman D Cytometry; 1997 Oct; 30(5):249-63. PubMed ID: 9383099 [No Abstract] [Full Text] [Related]
7. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189 [TBL] [Abstract][Full Text] [Related]
8. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Braylan RC; Atwater SK; Diamond L; Hassett JM; Johnson M; Kidd PG; Leith C; Nguyen D Cytometry; 1997 Oct; 30(5):245-8. PubMed ID: 9383098 [No Abstract] [Full Text] [Related]
10. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods. Zwick D; Cooley L; Hetherington M Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134 [TBL] [Abstract][Full Text] [Related]
11. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Borowitz MJ; Bray R; Gascoyne R; Melnick S; Parker JW; Picker L; Stetler-Stevenson M Cytometry; 1997 Oct; 30(5):236-44. PubMed ID: 9383097 [No Abstract] [Full Text] [Related]
12. In the realm for standardization in immunophenotyping. Tárnok A Cytometry A; 2012 Nov; 81(11):931-2. PubMed ID: 23090894 [No Abstract] [Full Text] [Related]
13. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Stelzer GT; Marti G; Hurley A; McCoy P; Lovett EJ; Schwartz A Cytometry; 1997 Oct; 30(5):214-30. PubMed ID: 9383095 [No Abstract] [Full Text] [Related]
14. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias. Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama J; Orfao A; Cytometry B Clin Cytom; 2006 Jan; 70(1):1-9. PubMed ID: 16278833 [TBL] [Abstract][Full Text] [Related]
15. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire]. Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262 [TBL] [Abstract][Full Text] [Related]
16. Quality control in clinical flow cytometry. Oldaker TA Clin Lab Med; 2007 Sep; 27(3):671-85, viii. PubMed ID: 17658412 [TBL] [Abstract][Full Text] [Related]
17. A multifaceted approach to diagnosis and classification of acute leukemia. McKenna RW Arch Pathol Lab Med; 1991 Apr; 115(4):328-30. PubMed ID: 2012493 [No Abstract] [Full Text] [Related]
18. More than just quality control. Carey JL; Oldaker TA Clin Lab Med; 2007 Sep; 27(3):687-707, ix. PubMed ID: 17658413 [TBL] [Abstract][Full Text] [Related]
19. Influence of 4- and 6-color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection. Ashman M; Sachdeva N; Davila L; Scott G; Mitchell C; Cintron L; Rathore M; Asthana D Cytometry B Clin Cytom; 2007 Sep; 72(5):380-6. PubMed ID: 17226862 [TBL] [Abstract][Full Text] [Related]
20. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. Kraan J; Gratama JW; Keeney M; D'Hautcourt JL J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607 [No Abstract] [Full Text] [Related] [Next] [New Search]